{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/ABUS/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-15T14:00:52.005Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":9992,"canonical_name":"Arbutus Biopharma Corp","cik":"0001447028","uei":null,"lei":null,"duns":null,"ticker":"ABUS"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":24,"clinical":1},"count":25,"timeline":[{"ts":"2026-10-07","kind":"sec.filing","form_type":"4","title":"4 — Arbutus Biopharma Corp — 2026-10-07","url_slug":"/sec/cik-0001447028/4/0001447028-26-000058","accession_number":"0001447028-26-000058","importance":30},{"ts":"2026-10-07","kind":"sec.filing","form_type":"4","title":"4 — Arbutus Biopharma Corp — 2026-10-07","url_slug":"/sec/cik-0001447028/4/0001447028-26-000059","accession_number":"0001447028-26-000059","importance":30},{"ts":"2026-10-07","kind":"sec.filing","form_type":"4","title":"4 — Arbutus Biopharma Corp — 2026-10-07","url_slug":"/sec/cik-0001447028/4/0001447028-26-000060","accession_number":"0001447028-26-000060","importance":30},{"ts":"2026-10-07","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Arbutus Biopharma Corp — 2026-10-07","url_slug":"/sec/cik-0001447028/schedule-13g-a/0000895421-26-000284","accession_number":"0000895421-26-000284","importance":30},{"ts":"2026-10-05","kind":"sec.filing","form_type":"SCHEDULE 13D/A","title":"SCHEDULE 13D/A — Arbutus Biopharma Corp — 2026-10-05","url_slug":"/sec/cik-0001447028/schedule-13d-a/0001140361-26-038693","accession_number":"0001140361-26-038693","importance":70},{"ts":"2026-10-05","kind":"sec.filing","form_type":"4","title":"4 — Arbutus Biopharma Corp — 2026-10-05","url_slug":"/sec/cik-0001447028/4/0001140361-26-038692","accession_number":"0001140361-26-038692","importance":30},{"ts":"2026-10-01","kind":"sec.filing","form_type":"SC TO-I/A","title":"SC TO-I/A — Arbutus Biopharma Corp — 2026-10-01","url_slug":"/sec/cik-0001447028/sc-to-i-a/0001104659-26-112579","accession_number":"0001104659-26-112579","importance":30},{"ts":"2026-09-30","kind":"sec.filing","form_type":"SC TO-I/A","title":"SC TO-I/A — Arbutus Biopharma Corp — 2026-09-30","url_slug":"/sec/cik-0001447028/sc-to-i-a/0001104659-26-112115","accession_number":"0001104659-26-112115","importance":30},{"ts":"2026-09-23","kind":"sec.filing","form_type":"4","title":"4 — Arbutus Biopharma Corp — 2026-09-23","url_slug":"/sec/cik-0001447028/4/0001447028-26-000051","accession_number":"0001447028-26-000051","importance":30},{"ts":"2026-09-23","kind":"sec.filing","form_type":"4","title":"4 — Arbutus Biopharma Corp — 2026-09-23","url_slug":"/sec/cik-0001447028/4/0001447028-26-000052","accession_number":"0001447028-26-000052","importance":30},{"ts":"2026-09-23","kind":"sec.filing","form_type":"4","title":"4 — Arbutus Biopharma Corp — 2026-09-23","url_slug":"/sec/cik-0001447028/4/0001447028-26-000053","accession_number":"0001447028-26-000053","importance":30},{"ts":"2026-09-04","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Arbutus Biopharma Corp — 2026-09-04","url_slug":"/sec/cik-0001447028/schedule-13g/0000921895-26-002494","accession_number":"0000921895-26-002494","importance":55},{"ts":"2026-08-24","kind":"sec.filing","form_type":"SC TO-I","title":"SC TO-I — Arbutus Biopharma Corp — 2026-08-24","url_slug":"/sec/cik-0001447028/sc-to-i/0001104659-26-100002","accession_number":"0001104659-26-100002","importance":30},{"ts":"2026-08-21","kind":"sec.filing","form_type":"8-K","title":"8-K — Arbutus Biopharma Corp — 2026-08-21","url_slug":"/sec/cik-0001447028/8-k/0001104659-26-099390","accession_number":"0001104659-26-099390","importance":35},{"ts":"2026-08-21","kind":"sec.filing","form_type":"SC TO-C","title":"SC TO-C — Arbutus Biopharma Corp — 2026-08-21","url_slug":"/sec/cik-0001447028/sc-to-c/0001104659-26-099391","accession_number":"0001104659-26-099391","importance":30},{"ts":"2026-08-12","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Arbutus Biopharma Corp — 2026-08-12","url_slug":"/sec/cik-0001447028/10-q/0001447028-26-000045","accession_number":"0001447028-26-000045","importance":45},{"ts":"2026-08-12","kind":"sec.filing","form_type":"8-K","title":"8-K — Arbutus Biopharma Corp — 2026-08-12","url_slug":"/sec/cik-0001447028/8-k/0001171843-26-005442","accession_number":"0001171843-26-005442","importance":35},{"ts":"2026-08-12","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Arbutus Biopharma Corp — 2026-08-12","url_slug":"/sec/cik-0001447028/schedule-13g-a/0000895421-26-000222","accession_number":"0000895421-26-000222","importance":30},{"ts":"2026-07-16","kind":"sec.filing","form_type":"8-K","title":"8-K — Arbutus Biopharma Corp — 2026-07-16","url_slug":"/sec/cik-0001447028/8-k/0001171843-26-004708","accession_number":"0001171843-26-004708","importance":35},{"ts":"2026-06-10","kind":"sec.filing","form_type":"4","title":"4 — Arbutus Biopharma Corp — 2026-06-10","url_slug":"/sec/cik-0001447028/4/0001447028-26-000040","accession_number":"0001447028-26-000040","importance":30},{"ts":"2026-06-05","kind":"sec.filing","form_type":"S-8","title":"S-8 — Arbutus Biopharma Corp — 2026-06-05","url_slug":"/sec/cik-0001447028/s-8/0001447028-26-000027","accession_number":"0001447028-26-000027","importance":30},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Arbutus Biopharma Corp — 2026-05-15","url_slug":"/sec/cik-0001447028/schedule-13g-a/0001011438-26-000347","accession_number":"0001011438-26-000347","importance":30},{"ts":"2026-05-13","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Arbutus Biopharma Corp — 2026-05-13","url_slug":"/sec/cik-0001447028/10-q/0001447028-26-000021","accession_number":"0001447028-26-000021","importance":45},{"ts":"2026-05-13","kind":"sec.filing","form_type":"8-K","title":"8-K — Arbutus Biopharma Corp — 2026-05-13","url_slug":"/sec/cik-0001447028/8-k/0001171843-26-003346","accession_number":"0001171843-26-003346","importance":35},{"ts":"2026-04-29","kind":"clinical.trial","reporter":"Arbutus Biopharma Corporation","title":"Open-Label Study of AB-729, Nucleos(t)Ide Analogue and Pegylated Interferon Alfa-2a in Subjects With Chronic Hepatitis B Infection","security_title":"PHASE2","status":"COMPLETED","accession_number":"NCT04980482","excerpt":"[\"Chronic Hepatitis b\"]","importance":45}]}